We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 145 results
  1. Non-myogenic mesenchymal cells contribute to muscle degeneration in facioscapulohumeral muscular dystrophy patients

    Muscle-resident non-myogenic mesenchymal cells play key roles that drive successful tissue regeneration within the skeletal muscle stem cell niche....

    Lorena Di Pietro, Flavia Giacalone, ... Ornella Parolini in Cell Death & Disease
    Article Open access 16 September 2022
  2. Meta-analysis towards FSHD reveals misregulation of neuromuscular junction, nuclear envelope, and spliceosome

    Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common autosomal dominant muscle disorders, yet no cure or amelioration exists. The...

    Teresa Schätzl, Vanessa Todorow, ... Matthias Kohl in Communications Biology
    Article Open access 25 May 2024
  3. Hypoxia enhances human myoblast differentiation: involvement of HIF1α and impact of DUX4, the FSHD causal gene

    Background

    Hypoxia is known to modify skeletal muscle biological functions and muscle regeneration. However, the mechanisms underlying the effects...

    Thuy-Hang Nguyen, Lise Paprzycki, ... Alexandra Tassin in Skeletal Muscle
    Article Open access 16 December 2023
  4. SMCHD1 and LRIF1 converge at the FSHD-associated D4Z4 repeat and LRIF1 promoter yet display different modes of action

    Facioscapulohumeral muscular dystrophy (FSHD) is caused by the epigenetic derepression of the 4q-linked D4Z4 macrosatellite repeat resulting in...

    Darina Šikrová, Alessandra M. Testa, ... Silvère M. van der Maarel in Communications Biology
    Article Open access 28 June 2023
  5. Meeting report: the 2021 FSHD International Research Congress

    Facioscapulohumeral muscular dystrophy (FSHD) is the second most common genetic myopathy, characterized by slowly progressing and highly...

    Sujatha Jagannathan, Jessica C. de Greef, ... Scott Q. Harper in Skeletal Muscle
    Article Open access 17 January 2022
  6. TRIM32 biallelic defects cause limb-girdle muscular dystrophy R8: identification of two novel mutations and investigation of genotype–phenotype correlation

    Background

    Limb-girdle muscular dystrophy R8 (LGMD R8) is a rare autosomal recessive muscle disease caused by TRIM32 gene biallelic defects. The...

    Yuqing Guan, **ongda Liang, ... Xuan Shang in Skeletal Muscle
    Article Open access 22 May 2023
  7. Flavones provide resistance to DUX4-induced toxicity via an mTor-independent mechanism

    Facioscapulohumeral muscular dystrophy (FSHD) is among the most common of the muscular dystrophies, affecting nearly 1 in 8000 individuals, and is a...

    Justin Cohen, Shushu Huang, ... Alec M. DeSimone in Cell Death & Disease
    Article Open access 16 November 2023
  8. Transgenic mice expressing tunable levels of DUX4 develop characteristic facioscapulohumeral muscular dystrophy-like pathophysiology ranging in severity

    Background

    All types of facioscapulohumeral muscular dystrophy (FSHD) are caused by the aberrant activation of the somatically silent DUX4 gene, the...

    Takako I. Jones, Guo-Liang Chew, ... Peter L. Jones in Skeletal Muscle
    Article Open access 11 April 2020
  9. The double homeodomain protein DUX4c is associated with regenerating muscle fibers and RNA-binding proteins

    Background

     We have previously demonstrated that double homeobox 4 centromeric ( DUX4C ) encoded for a functional DUX4c protein upregulated in...

    Clothilde Claus, Moriya Slavin, ... Frédérique Coppée in Skeletal Muscle
    Article Open access 07 March 2023
  10. Antiapoptotic Protein FAIM2 is targeted by miR-3202, and DUX4 via TRIM21, leading to cell death and defective myogenesis

    Inappropriate expression of DUX4, a transcription factor that induces cell death at high levels of expression and impairs myoblast differentiation at...

    Hossam A. N. Soliman, Erik A. Toso, ... Michael Kyba in Cell Death & Disease
    Article Open access 25 April 2022
  11. The ties that bind: functional clusters in limb-girdle muscular dystrophy

    The limb-girdle muscular dystrophies (LGMDs) are a genetically pleiomorphic class of inherited muscle diseases that are known to share phenotypic...

    Elisabeth R. Barton, Christina A. Pacak, ... Peter B. Kang in Skeletal Muscle
    Article Open access 29 July 2020
  12. Meeting report: the 2020 FSHD International Research Congress

    Michael Kyba, Robert J. Bloch, ... Yi-Wen Chen in Skeletal Muscle
    Article Open access 08 December 2020
  13. Revealing myopathy spectrum: integrating transcriptional and clinical features of human skeletal muscles with varying health conditions

    Myopathy refers to a large group of heterogeneous, rare muscle diseases. Bulk RNA-sequencing has been utilized for the diagnosis and research of...

    Huahua Zhong, Veronica Sian, ... Bjarne Udd in Communications Biology
    Article Open access 10 April 2024
  14. Rare paediatric disorders in Indian healthcare settings with focus on neuromuscular disorders: Diagnostic and management challenges

    Rare diseases form the bulk of the financial expenditure of any develo** or developed economy. Among the various rare diseases, paediatric...

    Aakash Mahesan, Gautam Kamila, Sheffali Gulati in Journal of Biosciences
    Article 10 January 2024
  15. Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data

    Single-cell RNA sequencing (scRNA-seq) distinguishes cell types, states and lineages within the context of heterogeneous tissues. However, current...

    Duanchen Sun, **angnan Guan, ... Zheng **a in Nature Biotechnology
    Article 11 November 2021
  16. Molecular mechanisms and therapeutic strategies for neuromuscular diseases

    Neuromuscular diseases encompass a heterogeneous array of disorders characterized by varying onset ages, clinical presentations, severity, and...

    Zambon Alberto Andrea, Falzone Yuri Matteo, ... Previtali Stefano Carlo in Cellular and Molecular Life Sciences
    Article Open access 28 April 2024
  17. DUX4, a Zygotic Genome Activator, Is Involved in Oncogenesis and Genetic Diseases

    Abstract

    After fertilization, the genome is transcriptionally quiescent to allow zygote reprogramming that relies on the RNA and proteins accumulated...

    Anna Karpukhina, Yegor Vassetzky in Russian Journal of Developmental Biology
    Article 01 May 2020
  18. Systemic cell therapy for muscular dystrophies

    The intrinsic regenerative capacity of skeletal muscle makes it an excellent target for cell therapy. However, the potential of muscle tissue to...

    C. Rosanne M. Ausems, Baziel G.M. van Engelen, ... Derick G. Wansink in Stem Cell Reviews and Reports
    Article Open access 21 December 2020
  19. Dnmt3b regulates DUX4 expression in a tissue-dependent manner in transgenic D4Z4 mice

    Background

    Facioscapulohumeral muscular dystrophy (FSHD) is a skeletal muscle disorder that is caused by derepression of the transcription factor DUX4...

    Linde F. Bouwman, Bianca den Hamer, ... Jessica C. de Greef in Skeletal Muscle
    Article Open access 01 October 2020
Did you find what you were looking for? Share feedback.